+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Activated Partial Thromboplastin Time"

From
Hemostasis Diagnostics - Global Strategic Business Report - Product Thumbnail Image

Hemostasis Diagnostics - Global Strategic Business Report

  • Report
  • May 2024
  • 173 Pages
  • Global
From
Coagulation Analyzer Global Market Report 2024 - Product Thumbnail Image

Coagulation Analyzer Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
Coagulation Analyzer Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Coagulation Analyzer Market - Forecasts from 2024 to 2029

  • Report
  • February 2024
  • 145 Pages
  • Global
From
From
Global Coagulation Testing Market 2021-2025 - Product Thumbnail Image

Global Coagulation Testing Market 2021-2025

  • Report
  • July 2021
  • 120 Pages
  • Global
From
From
From
From
From
Loading Indicator

The Activated Partial Thromboplastin Time (APTT) market is a segment of the coagulation and hemostasis testing industry. APTT tests measure the time it takes for a blood sample to clot, and are used to diagnose and monitor a variety of clotting disorders. APTT tests are used to detect deficiencies in the intrinsic and common pathways of the coagulation cascade, and are often used to monitor the effectiveness of anticoagulant therapy. The APTT market is highly competitive, with a variety of companies offering a range of products. These include instruments, reagents, and consumables. Companies in the market include Siemens Healthineers, Roche Diagnostics, Sysmex Corporation, Abbott Laboratories, and Ortho Clinical Diagnostics. Show Less Read more